Tag: EuroPCR 2025
EARLY TAVR: Analysis looks at trial’s outcomes based on guideline recommendations
New analysis of the EARLY TAVR trial, in which investigators examined the prevalence of guideline in...
Study intensifies call for randomised trial in patients with bicuspid aortic stenosis
The results of a retrospective analysis should act as a “word of caution” against the liberal us...
Stroke rates diverge among TAVI and surgery patients at five years in pragmatic trial
Long-term results of the UK TAVI trial, a pragmatic trial comparing transcatheter aortic valve i...
EuroPCR 2025: Thirty-day results show promise for Lux-Valve Plus TTVR system
Jenscare has announced the release of 30-day follow-up results of the TRINITY trial of the LuX-V...
EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms
New data comparing the Myval transcatheter aortic valve implantation (TAVI) system (Meril Life S...
EuroPCR 2025 hears early outcomes of Topaz TTVR system
TRiCares has announced the presentation of data in a late-breaking session at EuroPCR 2025 (20–2...
EuroPCR 2025: Sustained reduction in TR seen at two years with Triclip in real-world data
Two-year outcomes from the bRIGHT registry, a prospective multicentre registry detailing real-wo...
EuroPCR 2025: Search for suitable candidates for cerebral embolic protection continues
A pooled, individual patient-level data meta-analysis of two trials investigating the use of the Sen...
EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days
Thirty-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneo...
